IDH1 and nonpapillary renal cell carcinoma: The migration assay results displayed that the migration ability of ccRCC cell lines in IDH1 overexpressed group was reduced (P < 0.001, Figure 2E), and the migration ability of IDH1R132H inactivated mutation treatment group was not significantly changed (Figure 2E).